{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:01:23Z","timestamp":1791396083362,"version":"4.3.3"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":1750,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.ccr.2008.08.014","type":"journal-article","created":{"date-parts":[[2008,10,7]],"date-time":"2008-10-07T04:07:47Z","timestamp":1223352467000},"page":"335-343","source":"Crossref","is-referenced-by-count":213,"title":["Single-Cell Profiling Identifies Aberrant STAT5 Activation in Myeloid Malignancies with Specific Clinical and Biologic Correlates"],"prefix":"10.1016","volume":"14","author":[{"given":"Nikesh","family":"Kotecha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikki J.","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Irish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin F.","family":"Simonds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie S.","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Archambeault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Diaz-Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Coram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin M.","family":"Shannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garry P.","family":"Nolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mignon L.","family":"Loh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccr.2008.08.014_bib1","doi-asserted-by":"crossref","first-page":"7065","DOI":"10.1073\/pnas.96.12.7065","article-title":"Guanosine triphosphatase stimulation of oncogenic Ras mutants","volume":"96","author":"Ahmadian","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccr.2008.08.014_bib2","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nm1084","article-title":"Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation","volume":"10","author":"Araki","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccr.2008.08.014_bib3","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1182\/blood-2007-06-093302","article-title":"Development of an allele-specific minimal residual disease assay for patients with juvenile myelomonocytic leukemia","volume":"111","author":"Archambeault","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2008.08.014_bib4","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1182\/blood.V90.2.479","article-title":"Juvenile myelomonocytic leukemia","volume":"90","author":"Arico","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2008.08.014_bib5","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1182\/blood-2005-08-3522","article-title":"Implications of NRAS mutations in AML: a study of 2502 patients","volume":"107","author":"Bacher","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2008.08.014_bib6","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0022-3476(97)70273-7","article-title":"Occurrence of myeloproliferative disorder in patients with the Noonan syndrome","volume":"130","author":"Bader-Meunier","year":"1997","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ccr.2008.08.014_bib7","doi-asserted-by":"crossref","first-page":"6724","DOI":"10.1038\/sj.onc.1210757","article-title":"Hematopoietic cytokine receptor signaling","volume":"26","author":"Baker","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.ccr.2008.08.014_bib8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1097-2765(00)80415-3","article-title":"Nf1 and Gmcsf interact in myeloid leukemogenesis","volume":"5","author":"Birnbaum","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ccr.2008.08.014_bib9","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1073\/pnas.0307203101","article-title":"Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder","volume":"101","author":"Braun","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccr.2008.08.014_bib10","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1182\/blood-2006-07-036335","article-title":"Myeloproliferative disease induced by TEL-PDGFRB displays dynamic range sensitivity to Stat5 gene dosage","volume":"109","author":"Cain","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2008.08.014_bib11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00282-997-0041-4","article-title":"Chronic myelomonocytic leukemia: from biology to therapy","volume":"39","author":"Cambier","year":"1997","journal-title":"Hematol. Cell Ther."},{"key":"10.1016\/j.ccr.2008.08.014_bib12","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1172\/JCI20476","article-title":"Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease","volume":"113","author":"Chan","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ccr.2008.08.014_bib13","first-page":"203","article-title":"Juvenile myelomonocytic leukemia","volume":"3","author":"Emanuel","year":"2004","journal-title":"Curr. Hematol. Rep."},{"key":"10.1016\/j.ccr.2008.08.014_bib14","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood.V77.5.925.925","article-title":"Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors","volume":"77","author":"Emanuel","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2008.08.014_bib15","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2174\/138945007780830773","article-title":"Targeting RAS signaling pathways in juvenile myelomonocytic leukemia","volume":"8","author":"Flotho","year":"2007","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ccr.2008.08.014_bib16","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1182\/blood-2007-09-111831","article-title":"Genotype-phenotype correlation in cases of juvenile myelomonocytic leukemia with clonal RAS mutations","volume":"111","author":"Flotho","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2008.08.014_bib17","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1182\/blood-2002-02-0492","article-title":"The roles of FLT3 in hematopoiesis and leukemia","volume":"100","author":"Gilliland","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2008.08.014_bib18","doi-asserted-by":"crossref","first-page":"31704","DOI":"10.1074\/jbc.271.49.31704","article-title":"P210 and P190(BCR\/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members","volume":"271","author":"Ilaria","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ccr.2008.08.014_bib19","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cell.2004.06.028","article-title":"Single cell profiling of potentiated phospho-protein networks in cancer cells","volume":"118","author":"Irish","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.ccr.2008.08.014_bib20","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/nrc1804","article-title":"Mapping normal and cancer cell signalling networks: towards single-cell proteomics","volume":"6","author":"Irish","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccr.2008.08.014_bib21","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1182\/blood.V84.10.3435.3435","article-title":"Genetic analysis is consistent with the hypothesis that NF1 limits myeloid cell growth through p21ras","volume":"84","author":"Kalra","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2008.08.014_bib22","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1182\/blood-2006-05-025395","article-title":"Beta common receptor inactivation attenuates myeloproliferative disease in Nf1 mutant mice","volume":"109","author":"Kim","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2008.08.014_bib23","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1182\/blood-2005-02-0531","article-title":"The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome\/myeloproliferative disease","volume":"106","author":"Kratz","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2008.08.014_bib24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1476-4598-2-23","article-title":"Molecular responses to hypoxia in tumor cells","volume":"2","author":"Kunz","year":"2003","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ccr.2008.08.014_bib25","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1182\/blood-2003-08-2650","article-title":"Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorder","volume":"103","author":"Le","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2008.08.014_bib26","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1182\/blood-2005-05-1898","article-title":"The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia","volume":"106","author":"Levine","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2008.08.014_bib27","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1182\/blood-2004-05-1944","article-title":"Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS\/EBMT trial","volume":"105","author":"Locatelli","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2008.08.014_bib28","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1182\/blood-2003-09-3287","article-title":"Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis","volume":"103","author":"Loh","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2008.08.014_bib29","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.leukres.2004.10.001","article-title":"Acquired PTPN11 mutations occur rarely in adult patients with myelodysplastic syndromes and chronic myelomonocytic leukemia","volume":"29","author":"Loh","year":"2005","journal-title":"Leuk. Res."},{"key":"10.1016\/j.ccr.2008.08.014_bib30","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.1182\/blood-2006-09-046649","article-title":"Spontaneous improvement of hematologic abnormalities in patients having juvenile myelomonocytic leukemia with specific RAS mutations","volume":"109","author":"Matsuda","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2008.08.014_bib31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/sj.leu.2401657","article-title":"Serine\/threonine phosphorylation in cytokine signal transduction","volume":"14","author":"McCubrey","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.ccr.2008.08.014_bib32","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1182\/blood-2003-01-0137","article-title":"Activating mutations of RTK\/ras signal transduction pathway in pediatric acute myeloid leukemia","volume":"102","author":"Meshinchi","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2008.08.014_bib33","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ccr.2005.01.010","article-title":"Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutations","volume":"7","author":"Mohi","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccr.2008.08.014_bib34","first-page":"3534","article-title":"Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS)","volume":"89","author":"Niemeyer","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2008.08.014_bib35","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1182\/blood.V99.3.840","article-title":"Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients","volume":"99","author":"Onida","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2008.08.014_bib36","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/cyto.a.20258","article-title":"A new \u201cLogicle\u201d display method avoids deceptive effects of logarithmic scaling for low signals and compensated data","volume":"69","author":"Parks","year":"2006","journal-title":"Cytometry A"},{"key":"10.1016\/j.ccr.2008.08.014_bib37","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.cytogfr.2004.09.001","article-title":"STATs as critical mediators of signal transduction and transcription: lessons learned from STAT5","volume":"15","author":"Paukku","year":"2004","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.ccr.2008.08.014_bib38","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1038\/sj.onc.1205398","article-title":"JAKs, STATs and Src kinases in hematopoiesis","volume":"21","author":"Rane","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.ccr.2008.08.014_bib39","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/ng1748","article-title":"Germline KRAS mutations cause Noonan syndrome","volume":"38","author":"Schubbert","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccr.2008.08.014_bib40","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/nri1226","article-title":"Regulation of JAK-STAT signalling in the immune system","volume":"3","author":"Shuai","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ccr.2008.08.014_bib41","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1182\/blood-2005-03-1183","article-title":"The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both \u201catypical\u201d myeloproliferative disorders and myelodysplastic syndromes","volume":"106","author":"Steensma","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2008.08.014_bib42","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/sj.leu.2404955","article-title":"Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms","volume":"22","author":"Tefferi","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.ccr.2008.08.014_bib43","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1182\/blood-2007-04-083501","article-title":"Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel","volume":"110","author":"Tefferi","year":"2007","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.ccr.2008.08.014_bib44","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.leukres.2003.10.005","article-title":"Mechanisms of transformation by the BCR-ABL oncogene: new perspectives in the post-imatinib era","volume":"28","author":"Van Etten","year":"2004","journal-title":"Leuk. Res."},{"key":"10.1016\/j.ccr.2008.08.014_bib45","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1182\/blood-2006-09-047530","article-title":"K-RasG12D expression induces hyperproliferation and aberrant signaling in primary hematopoietic stem\/progenitor cells","volume":"109","author":"Van Meter","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2008.08.014_bib46","doi-asserted-by":"crossref","first-page":"5995","DOI":"10.1038\/sj.onc.1206846","article-title":"Catalytic-dependent and -independent roles of SHP-2 tyrosine phosphatase in interleukin-3 signaling","volume":"22","author":"Yu","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.ccr.2008.08.014_bib47","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/sj.leu.2404484","article-title":"JAK2 V617F mutation is a rare event in juvenile myelomonocytic leukemia","volume":"21","author":"Zecca","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.ccr.2008.08.014_bib48","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1182\/blood-2002-12-3627","article-title":"FLT3 internal tandem duplication in 234 children with acute myeloid leukemia: prognostic significance and relation to cellular drug resistance","volume":"102","author":"Zwaan","year":"2003","journal-title":"Blood"}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610808002936?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610808002936?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T18:38:03Z","timestamp":1588963083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610808002936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S1535610808002936"],"URL":"https:\/\/doi.org\/10.1016\/j.ccr.2008.08.014","relation":{},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}